Please note: You are viewing the unstyled version of this site, either your browser does not support CSS (Cascading Style Sheets) or it has been disabled.
Skip to : [Content] [Navigation]
Clinical Validation

Clinical Validation:

Multiple prospective clinical trials involving a total of over 3,000 subjects have clearly demonstrated the prediabetes and type 2 diabetes screening accuracy of SCOUT DS. To find out more, click on the links below.


 

 

The SCOUT DS

SCOUT DS uses visible light to noninvasively measure changes in a person's skin indicative of prediabetes and type 2 diabetes, enabling cost-effective, opportunistic screening of those at risk.


No blood - No fasting - No waiting.

 

SCOUT in now available around the world

The SCOUT DS is now available in the following regions:

  • North America
  • Europe
  • Middle East/Africa
  • Asia pacific
  • South America
  • more...